A

Acumen Pharmaceuticals
D

ABOS

1.66000
USD
-0.09
(-4.87%)
مغلق
حجم التداول
33,914
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
120,046,693

العنوان: Acumen Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.